This amendment provides $23,625 from the general fund in fiscal year 2026 to implement the provisions of House Bill 1641, pursuant to its passage during the 2025 Regular Session, to defray the cost of mandating qualified health plans to cover the diagnosis and treatment of pediatric autoimmune disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS). The funding defrays the costs to include the coverage provided through qualified health plans sold through Virginia's Insurance Marketplace, the state's health benefit exchange.